Integer Holdings (ITGR) Liabilities and Shareholders Equity (2010 - 2026)
Integer Holdings (ITGR) reported Liabilities and Shareholders Equity of $3.4 billion for Q2 2026, up 3.46% on a YoY basis from $3.3 billion in Q2 2025, and little changed sequentially from $3.4 billion in Q4 2025.
Integer Holdings (ITGR) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Integer Holdings (ITGR) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $3.4 billion in Q2 2026.
- For the quarter ending Q2 2026, Liabilities and Shareholders Equity rose 3.46% year-over-year to $3.4 billion; the trailing twelve-month figure through Apr 2026 stood at $13.6 billion (up 7.27% YoY), and the FY2025 full-year result was $3.4 billion, up 10.81% from the prior year.
- Liabilities and Shareholders Equity was little changed at $3.4 billion in Q2 2026, from $3.4 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $3.4 billion in Q2 2026 to a low of $2.6 billion in Q2 2022.
- A 5-year average of $3.0 billion and a median of $3.1 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
- Across the five-year window, Liabilities and Shareholders Equity gained 16.91% in 2022 and advanced 3.46% in 2026, its largest moves.
- Tracing ITGR's Liabilities and Shareholders Equity over 5 years: stood at $2.8 billion in 2022, then gained by 5.31% to $2.9 billion in 2023, then grew by 4.6% to $3.1 billion in 2024, then advanced by 10.81% to $3.4 billion in 2025, then gained by 0.03% to $3.4 billion in 2026.
- Business Quant data shows ITGR's Liabilities and Shareholders Equity at $3.4 billion in Q2 2026, $3.4 billion in Q4 2025, and $3.4 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.89 Bn | 173.59 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 127.82 Bn | 124.94 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 107.49 Bn | 98.27 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 67.24 Bn | 65.78 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 48.02 Bn | 44.34 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Dexcom | 28.25 Bn | 27.14 Bn | 750.30 Mn | 6.63 Bn |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.89 Bn | 1.98 Bn | 37.13 Bn |
| 8 | Smith & Nephew | 26.72 Bn | 26.14 Bn | - | 10.46 Bn |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | 31.92 Bn |
| 10 | Integer Holdings | 3.39 Bn | 3.38 Bn | 109.60 Mn | 3.41 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 3.41 Bn |
| Dec 31, 2025 | 3.41 Bn |
| Sep 26, 2025 | 3.40 Bn |
| Jun 27, 2025 | 3.37 Bn |
| Mar 28, 2025 | 3.30 Bn |
| Dec 31, 2024 | 3.08 Bn |
| Sep 27, 2024 | 3.17 Bn |
| Jun 28, 2024 | 3.13 Bn |
| Mar 29, 2024 | 3.12 Bn |
| Dec 31, 2023 | 2.94 Bn |
| Sep 29, 2023 | 2.84 Bn |
| Jun 30, 2023 | 2.86 Bn |
| Mar 31, 2023 | 2.87 Bn |
| Dec 31, 2022 | 2.79 Bn |
| Sep 30, 2022 | 2.74 Bn |
| Jul 1, 2022 | 2.76 Bn |
| Apr 1, 2022 | 2.61 Bn |
| Dec 31, 2021 | 2.58 Bn |
| Oct 1, 2021 | 2.35 Bn |
| Jul 2, 2021 | 2.36 Bn |